NL7506743A - DIAGNOSTIC. - Google Patents

DIAGNOSTIC.

Info

Publication number
NL7506743A
NL7506743A NL7506743A NL7506743A NL7506743A NL 7506743 A NL7506743 A NL 7506743A NL 7506743 A NL7506743 A NL 7506743A NL 7506743 A NL7506743 A NL 7506743A NL 7506743 A NL7506743 A NL 7506743A
Authority
NL
Netherlands
Prior art keywords
june
blood plasma
water
intravascularly
subsequent
Prior art date
Application number
NL7506743A
Other languages
Dutch (nl)
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of NL7506743A publication Critical patent/NL7506743A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/003—Crosslinking of starch
    • C08B31/006—Crosslinking of derivatives of starch
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Endocrinology (AREA)
  • Materials Engineering (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

1518813 Diagnostic agents PHARMACIA AB 5 June 1975 [6 June 1974] 24287/75 Heading A5B [Also in Divisions C3 and G1] A diagnostic agent for intravascular administration and subsequent analysis in vivo or in vitro consists of a radioactive component, e.g. Tc<SP>99m</SP> (e.g. sodium pertechnetate) which is bound to, and/or enclosed in and/or exists in admixture with particles of a water-insoluble but hydrophilic, swellable, three dimensional network of molecules of a polyglucose polymer or physiologically acceptable derivative thereof which is cross linked covalently, the network being degradable by 2-amylase in blood plasma into water-soluble fragments either directly or subsequent to a preliminary splitting-off of substituents which may be present in the polysaccharide through the action of an enzyme in blood plasma (see Division C3). The compositions may be administered intravascularly whereafter the radioactive radiation is measured over the relevant body portion or on a sample taken from the body (e.g. an intravascularly taken sample).
NL7506743A 1974-06-06 1975-06-06 DIAGNOSTIC. NL7506743A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7407461A SE420566B (en) 1974-06-06 1974-06-06 DIAGNOSTIZER FOR INTRAVASCULAR ADMINISTRATION

Publications (1)

Publication Number Publication Date
NL7506743A true NL7506743A (en) 1975-12-09

Family

ID=20321348

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7506743A NL7506743A (en) 1974-06-06 1975-06-06 DIAGNOSTIC.

Country Status (8)

Country Link
JP (1) JPS517113A (en)
AU (1) AU8164675A (en)
CA (1) CA1039274A (en)
DE (1) DE2524278A1 (en)
FR (1) FR2273516A1 (en)
GB (1) GB1518813A (en)
NL (1) NL7506743A (en)
SE (1) SE420566B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0093757A1 (en) * 1981-11-12 1983-11-16 Ulf SCHRÖDER Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof
FR2548902B1 (en) * 1983-07-13 1986-04-11 Guerbet Sa THERAPEUTIC EMBOLIZATION GEL
SE463651B (en) * 1983-12-21 1991-01-07 Nycomed As DIAGNOSTIC AND CONTRACTOR

Also Published As

Publication number Publication date
FR2273516A1 (en) 1976-01-02
FR2273516B1 (en) 1979-01-05
GB1518813A (en) 1978-07-26
DE2524278A1 (en) 1975-12-18
CA1039274A (en) 1978-09-26
JPS517113A (en) 1976-01-21
AU8164675A (en) 1976-12-02
SE7407461L (en) 1975-12-08
SE420566B (en) 1981-10-19

Similar Documents

Publication Publication Date Title
EP0787017B2 (en) Diagnostic preparation for detection of helicobacter pylori
CA1165686A (en) Radioactive diagnostic agent and non-radioactive carrier therefor
DE3578647D1 (en) PARAMAGNETIC CONTRAST AGENTS FOR USE IN &#34;IN VIVO&#34; NMR DIAGNOSTIC METHODS AND THE PRODUCTION THEREOF.
JPS60155138A (en) Manufacture of heparin or heparinoid with improved intestinal absorption and medicine thereof
US4071613A (en) Stabilized alcohol solution of reducing salt formulations for use in preparing radioisotope labeled scanning agents: liver scanning technetium-99m colloid and method of preparation
Whitby Enzymic formation of a new riboflavin derivative
SE420566B (en) DIAGNOSTIZER FOR INTRAVASCULAR ADMINISTRATION
Schilsky et al. Biliary copper excretion capacity in intact animals: correlation between ATP7B function, hepatic mass, and biliary copper excretion
Ekenved ABSORPTION FROM DIFFERENT TYPES OF IRON TABLETS‐CORRELATION BETWEEN SERUM IRON INCREASE AND TOTAL ABSORPTION OF IRON
EP0063946A1 (en) Diagnosis of kidney function
Esquerre et al. Kinetics of technetium-labeled heparin in thromboembolism: Preliminary Report
Ainsworth An ultrastructural method for the use of polyvinylpyrrolidone and dextrans as electron opaque tracers.
EP0413145A1 (en) Radioactive diagnostic agent
Caputo et al. Letterer-Siwe disease in an octogenarian
Hudson et al. Tumour uptake of thallium-201 chloride
Turan et al. Evaluation of 99m Tc-citrate, 67 Gacitrate and 99m Tc (V) dimercaptosuccinic acid for the scintigraphic visualization of acute appendicitis
Rosenau Dangers in the use of certain halogenated phthaleins as functional tests
JPS5842846B2 (en) Technetium-99m labeled radiological diagnostic agent for liver and bone marrow scanning and its manufacturing method
JPS63170400A (en) Radioactive medicine and high polymer compound for preparation thereof
GB2055044A (en) Glucuronidase activity and/or phdependent pharmaceuticals and their methods of production and use for selective treatment of diseases
WO2023201377A3 (en) Scission-enhanced nuclear imaging and treatment
Duchon Tyrosine metabolism in melanoma
JPS60126231A (en) Radioactie diagnostic agent
Perin et al. Evaluation of possible interference of anti-inflammatory drugs upon scintigraphic imaging with macrophage targeting 99mTc-J001X: Effects of methylprednisolone, dexamethasone, indomethacin and methotrexate
DE69530841T2 (en) RADIOACTIVELY MARKED ANNEXIN GALACTOSE CONJUGATES

Legal Events

Date Code Title Description
BV The patent application has lapsed